BMI View: The Slovakian pharmaceutical market will remain one of the most attractive markets in CEE.
While the authorities continue to impose stringent pricing controls, limiting patented medicine access, there
is clear motivation to widen innovative drug access to ..."
BMI View: Slovakia will remain a modest investment opportunity for multinational drugmakers. While
expenditure for both healthcare and pharmaceuticals is high, greater funding efficiency is needed. Recent
years have been turbulent for the healthcare sector, with a lac ..."
BMI View: Improving domestic economic outlook will provide a boost to healthcare expenditure in
Slovakia in the short term. Over the longer term, we expect healthcare spending to accelerate, given
Slovakia's ageing population and burden of chronic diseases. With publi ..."
BMI View: Despite Slovakia's declining disease burden, multinational drugmakers will continue to target
the country given the sizeable proportion of non-communicable diseases. Slovakia's cardiovascular drug
market will prove to be the most lucrative, with cardiovascul ..."
BMI View: The acceleration in the rolling out of eHealth technologies is positive for the country's
healthcare sector, but Slovakian authorities will need to press ahead in order to meet upcoming EU
deadlines. eHealth will improve the efficient running of the country' ..."
BMI View: Eurozone recovery and an improving domestic economic outlook will provide a boost to
healthcare expenditure in Slovakia in the short-term. Over the longer term, we expect healthcare spending
to accelerate given Slovakia's ageing population and burden of chro ..."
BMI View: In 2014, almost 2.47% of the country's GDP was spent on pharmaceuticals, as combined sales
of prescription drugs and over-the-counter medicines - sold through pharmacies and hospitals at consumer
prices - reached EUR1.85bn (USD2.46bn). Although total pharmac ..."
BMI View: Hospitals' and doctors' medical fees are symptomatic of the chronic inefficiency of healthcare
funding within Slovakia. This is underscored by the Organisation for Economic Co-operation and
Development (OECD)'s finding that even though healthcare spending in Slovakia ..."
BMI View: The Slovakian health ministry has introduced orders to reign in medical fees charged by
doctors and outpatient physician, with rules set to enter effect from autumn this year. Medical fees by
hospitals and doctors are symptomatic of the chronic inefficiency ..."
BMI View: The Slovakian government is planning to allocate EUR278mn (USD386.7mn) in EU funding to
develop healthcare and medical infrastructure in Slovakia over the 2014-2020 period, reports news agency
TASR. The government added that after adding contributions from the state b ..."